// App-Quantinova.ai

: Graft-Versus-Host-Disease Prophylaxis with ATG or Ptcy in Patients with Lymphoproliferative Disorders Undergoing Reduced Intensity Conditioning Regimen 9/10 Mmud HCT

Researchers

Presenter

  • Annalisa Paviglianiti

Principal Investigators

  • Alberto Mussetti

  • Maud Ngoya

  • Ariane Boumendil

  • Zafer Gulbas

  • Fabio Ciceri

  • Francesca Bonifazi

  • Domenico Russo

  • Nathalie Fegueux

  • Friedrich Stolzel

  • Claude-Eric Bulabois

  • Gerard Socie

  • Edouard Forcade

  • Carlos Solano

  • Herve Finel

  • Stephen Robinson

  • Silvia Montoto

  • Bertram Glass

Medical Centers

  • Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, Barcelona, Spain

  • Anadolu Medical Center Hospital, Bone Marrow Transplantation Department, Kocaeli, Turkey

  • EBMT Lymphoma Working Party Paris Office, Paris, France

  • Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Spain

  • University Hospital, TU Dresden,Germany, Dresden, Germany

  • Department of Hematology and Cell Therapy, EBMT Paris Study Office, Paris, France

  • Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

  • Department of Hematology - BMT, Hopital St. Louis, Paris, France

  • Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany

  • Lymphoma Working Party, EBMT Central Registry Office, Paris, France

  • University Hospital Bristol, Bristol, United Kingdom

  • Unit of Blood Diseases and Bone Marrow Transplantation, ASST Spedali Civili, University of Brescia, ASST Spedali Civili, Brescia, Italy

  • Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France

  • Department of Medicine, University of Valencia, Valencia, Spain

  • Service d'Hématologie, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France

  • Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom

  • Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France

  • Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain

  • EBMT Lymphoma Working Party and St. Bartholomew´s Hospital, Barts Health NHS Trust, London, United Kingdom

Locations

  • Spain

  • France

  • Turkey

  • Italy

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Lympho proliferative disease

  • Graft-versus-host disease

Biomarkers

  • Hematocrit

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved